Insurance Coverage: Many major insurance plans no longer cover Arnuity Ellipta. Learn More
Tori Marsh - September 17, 2018
Smoke from more than 50 massive wildfires across the Western United States is spreading, causing smoky skies, breathing challenges, and high prescription fill rates for asthma medications—even for cities in the Midwest and on the East Coast.
According to a nationally representative sample of prescriptions, fills for asthma medications this July and August were more than 20% higher than normal in Oregon, Washington, Montana and Northern California. See More
Tori Marsh - August 08, 2018
This year has been tough for people with asthma. Pollen season ran especially long and just weeks after it peaked, we now have the California wildfires spreading smoke to the majority of US states and causing a spike in symptom flare ups. On top of that, asthma inhalers today are expensive. Popular ones can cost upwards of $500 per month and many are inadequately covered by insurance plans.
So what’s going on with insurance coverage for these lifesaving medications and how can you save? First, high-deductible health plans (HDHPs) and restrictions on coverage are two ways insurance can leave you with a heavy bill. See More
Tori Marsh - May 29, 2018
First approved in 2014 for patients 12 years of age and older, Arnuity Ellipta (fluticasone) is a popular inhaler used in the long-term management of asthma. Now, the inhaler can also be prescribed to younger children — as of May 2018, Arnuity Ellipta is FDA-approved for treating asthma in kids as young as 5 years old.
While this does expand treatment options for young children, Arnuity Ellipta is expensive and can be unaffordable for many. See More
Elizabeth Davis - August 12, 2015
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
Roni Shye - April 08, 2015
When you drop off your medications at a pharmacy you may notice that the technician, intern, or pharmacist who greets you and takes your prescriptions may also ask you for an updated list of your allergies.
I have seen some patients annoyed by this life-saving question, while others seem to blow it off. Some of the remarks I have heard include, “It’s on file, I told you last time,” to “You don’t need to know this information. See More
Roni Shye - March 13, 2015
Breo Ellipta (fluticasone furoate and vilanterol), an inhalation powder used for the treatment of COPD, was the first Ellipta inhaler to become available back in 2013. Over the past two years or so, several more Ellipta options have entered the market.
Ellipta medications tend to be a bit more expensive, but some people prefer them to more traditional types of inhalers.
So, what is unique about the Ellipta device?
The Ellipta from GlaxoSmithKline (GSK) is their new platform inhalation device. See More
Roni Shye - September 08, 2014
Arnuity Ellipta (fluticasone furoate) is the newest corticosteroid inhaler approved for the long-term maintenance treatment of airflow obstruction in patients with asthma. It was approved by the FDA on August 20, 2014.
When will Arnuity Ellipta be available?
At this time the manufacturer, GlaxoSmithKline, has not set a release date.